ISB News

Lee Hood Among Featured Innovators at Bezos Center for Innovation at MOHAI

MOHAI

On Oct. 11, MOHAI hosted a VIP event to celebrate the launch of the Bezos Center for Innovation. The exhibit features 13 innovators from the Seattle area, including ISB’s president, Dr. Lee Hood. Each innovator sat for an interview and snippets from each interview are woven throughout the exhibit on touchscreens.

Event attendees included Dennis Hayes, below left, who founded Earth Day. He and Lee Hood, below right, spent a few moments catching up.

Hayes and Hood

Once the ceremony began, Gov. Jay Inslee welcomed the audience and praised innovation in Washington State, extending an extra note of thanks to the Jeff Bezos for his support of MOHAI.

Gov. Jay Inslee

Leonard Garfield, executive director of MOHAI, pictured below left, then conducted a question-and-answer session with Jeff Bezos. Here’s a great write-up in Geekwire.com of the event and some photos of the exhibit.

Bezos interview

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.